CY1117407T1 - Διαχωρισμος των εναντιομερων παραγωγων τριαζινης με χρηση τρυγικου οξεος - Google Patents

Διαχωρισμος των εναντιομερων παραγωγων τριαζινης με χρηση τρυγικου οξεος

Info

Publication number
CY1117407T1
CY1117407T1 CY20151100823T CY151100823T CY1117407T1 CY 1117407 T1 CY1117407 T1 CY 1117407T1 CY 20151100823 T CY20151100823 T CY 20151100823T CY 151100823 T CY151100823 T CY 151100823T CY 1117407 T1 CY1117407 T1 CY 1117407T1
Authority
CY
Cyprus
Prior art keywords
triazine
eniometries
tragic
producers
acid
Prior art date
Application number
CY20151100823T
Other languages
English (en)
Inventor
Daniel Cravo
Matthias Helmreich
Original Assignee
Poxel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poxel filed Critical Poxel
Publication of CY1117407T1 publication Critical patent/CY1117407T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/10—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με μία νέα διαδικασία διαχωρισμού των εναντιομερών παραγώγων τριαζίνης που περιλαμβάνει τρυγικό οξύ.
CY20151100823T 2010-12-01 2015-09-18 Διαχωρισμος των εναντιομερων παραγωγων τριαζινης με χρηση τρυγικου οξεος CY1117407T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10306327 2010-12-01
EP11788512.9A EP2646422B1 (en) 2010-12-01 2011-11-30 Separation of triazine derivatives enantiomers using tartaric acid

Publications (1)

Publication Number Publication Date
CY1117407T1 true CY1117407T1 (el) 2017-04-26

Family

ID=45047827

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100823T CY1117407T1 (el) 2010-12-01 2015-09-18 Διαχωρισμος των εναντιομερων παραγωγων τριαζινης με χρηση τρυγικου οξεος

Country Status (24)

Country Link
US (1) US8742103B2 (el)
EP (1) EP2646422B1 (el)
JP (1) JP5758010B2 (el)
KR (1) KR101530924B1 (el)
CN (1) CN103228635B (el)
AU (1) AU2011334992B2 (el)
BR (1) BR112013010115B1 (el)
CA (1) CA2816357C (el)
CY (1) CY1117407T1 (el)
DK (1) DK2646422T3 (el)
EA (1) EA022300B1 (el)
ES (1) ES2548038T3 (el)
HR (1) HRP20151022T1 (el)
HU (1) HUE026090T2 (el)
IL (1) IL226053A (el)
ME (1) ME02208B (el)
MX (1) MX345822B (el)
PL (1) PL2646422T3 (el)
PT (1) PT2646422E (el)
RS (1) RS54397B1 (el)
SI (1) SI2646422T1 (el)
SM (1) SMT201500230B (el)
TW (1) TWI428311B (el)
WO (1) WO2012072663A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019069230A1 (en) 2017-10-02 2019-04-11 Poxel METHODS OF TREATING CARDIAC INSUFFICIENCY WITH PRESERVED EJECTION FRACTION
AU2019282727A1 (en) 2018-06-06 2020-11-26 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
MX2020013567A (es) 2018-06-14 2021-05-27 Poxel Tableta recubierta con pelicula que comprende un derivado de triazina para su uso en el tratamiento de la diabetes.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804113B1 (fr) 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
US7458318B2 (en) 2006-02-01 2008-12-02 Speedline Technologies, Inc. Off-axis illumination assembly and method
DE102008007314A1 (de) 2008-02-02 2009-08-06 Merck Patent Gmbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5-triazinderivaten
HUE027532T2 (en) 2008-05-23 2016-10-28 Poxel Sas Process for the preparation of 3,6-dihydro-1,3,5-triazine derivatives

Also Published As

Publication number Publication date
AU2011334992B2 (en) 2016-03-24
KR20130093160A (ko) 2013-08-21
EP2646422A1 (en) 2013-10-09
PL2646422T3 (pl) 2015-12-31
ME02208B (me) 2016-02-20
US20130261300A1 (en) 2013-10-03
KR101530924B1 (ko) 2015-06-23
MX2013006017A (es) 2013-07-15
HUE026090T2 (en) 2016-05-30
AU2011334992A1 (en) 2013-05-30
DK2646422T3 (en) 2015-10-05
EA022300B1 (ru) 2015-12-30
CA2816357C (en) 2015-04-28
WO2012072663A1 (en) 2012-06-07
MX345822B (es) 2017-02-17
JP2014504281A (ja) 2014-02-20
JP5758010B2 (ja) 2015-08-05
EP2646422B1 (en) 2015-07-08
PT2646422E (pt) 2015-10-20
CN103228635A (zh) 2013-07-31
SMT201500230B (it) 2015-10-30
BR112013010115B1 (pt) 2018-12-04
IL226053A (en) 2015-03-31
WO2012072663A9 (en) 2012-08-30
RS54397B1 (en) 2016-04-28
IL226053A0 (en) 2013-06-27
ES2548038T3 (es) 2015-10-13
TW201228999A (en) 2012-07-16
BR112013010115A2 (pt) 2016-07-05
EA201300650A1 (ru) 2013-11-29
CA2816357A1 (en) 2012-06-07
US8742103B2 (en) 2014-06-03
HRP20151022T1 (hr) 2015-12-18
SI2646422T1 (sl) 2016-02-29
TWI428311B (zh) 2014-03-01
CN103228635B (zh) 2016-03-30

Similar Documents

Publication Publication Date Title
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
BR112012028395A2 (pt) processo para preparar ditiina-tetracarboxi-diimidas
DK2736837T3 (da) Fremgangsmåde til fremstilling af nanosiliciumtråde
BR112016029333A2 (pt) síntese de compostos de carbamoilpiridona policíclico
BR112014019909A8 (pt) Processo para produção de compostos úteis como antagonistas do receptor de orexina-2
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
CR20150271A (es) Peptidos como agonistas de oxitocina
UA110813C2 (uk) Лікування ліподистрофії
UY34108A (es) ?proceso para la fabricación de sustratos revestidos?.
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
MX2015002487A (es) Proceso para la preparacion de teneligliptina.
CR20150084A (es) 2-oxo-2,3-dihidro-indoles
MY164954A (en) Method for purifying organic diphosphite compounds
UY34719A (es) Proceso para la producción de inhibidores de crr
IN2013MU03070A (el)
UY34770A (es) ?un proceso para la producción de ácido metacrílico y sus derivados y polímeros producidos a partir de estos?.
CY1117407T1 (el) Διαχωρισμος των εναντιομερων παραγωγων τριαζινης με χρηση τρυγικου οξεος
BR112012026157A2 (pt) processo para preparar ditiina-tetracarboximidas.
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
CR20140564A (es) Derivados de pirimidinona como agentes antimaláricos
WO2014068599A3 (en) Process for pralatrexate
IN2014DN09451A (el)
IN2015DN00725A (el)
MX349985B (es) Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi.
MX2014003936A (es) Procedimiento para preparar ditiina-tetracarboximidas.